Apidra Vials

Apidra Vials contain insulin glulisine, a rapid-acting insulin used to help control blood sugar levels in people with type 1 and type 2 diabetes. This insulin works quickly to lower blood sugar during meals and is typically used with a longer-acting insulin for full-day glucose management. Apidra from vials is injected using a syringe and is often preferred for those who need flexible dosing or higher volumes.

Benefits

• Rapidly lowers blood sugar during and after meals
• Offers flexible dosing when using syringes
• Suitable for adults and children with diabetes as prescribed
• Can be combined with longer-acting insulin for balanced blood sugar control
• Helps reduce the risk of long-term diabetes complications when used consistently

Dosage

• The dose is individualized based on your doctor’s recommendation and blood sugar monitoring
• Apidra is usually injected within 15 minutes before a meal or within 20 minutes after starting a meal
• The typical starting dose may range from 4 to 6 units per meal, but exact amounts depend on your needs
• Always use a new sterile syringe and needle for each injection
• Inject under the skin of the abdomen, thigh, or upper arm, and rotate sites to prevent skin problems
• Carefully measure doses with an insulin syringe as directed by your healthcare provider

Warnings and Precautions

• Double-check the insulin label to ensure you are using the correct insulin type
• Apidra should be clear and colorless; do not use if cloudy or contains particles
• Let your doctor know if you have liver, kidney, or heart problems before starting Apidra
• Be aware of low blood sugar (hypoglycemia) symptoms, such as sweating, shakiness, or dizziness
• Carry fast-acting glucose sources, such as tablets or juice, in case of low blood sugar episodes
• Inform your doctor about any other medications that may affect your blood sugar levels

Usage Instructions

• Wash hands before preparing your insulin dose
• Draw the prescribed dose into an insulin syringe carefully, making sure to remove air bubbles
• Inject under the skin and hold the syringe in place for a few seconds to ensure the full dose is delivered
• Rotate injection sites to avoid hardening or thickening of the skin
• Do not share syringes, needles, or vials with others to prevent infections
• Dispose of used syringes and needles in a sharps container

Storage Information

• Store unopened vials in the refrigerator between 2°C and 8°C (36°F and 46°F)
• Once opened, a vial may be kept at room temperature below 25°C (77°F) and used within 28 days
• Do not freeze Apidra, and do not use if it has been frozen
• Keep away from direct heat or sunlight
• Always keep out of reach of children and pets

Common Side Effects

• Low blood sugar, which may cause sweating, shakiness, or fast heartbeat
• Mild pain, redness, or swelling at the injection site
• Weight gain if doses are not properly adjusted
• Rare allergic reactions may include rash or difficulty breathing and need immediate medical attention
• Skin changes like thickening or lumps at injection sites if not rotated

More information about Apidra

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide